Filter by: patients
Home > Community Treatment Reports and Side Effects > Green Tea Caps/Tabs Treatment Report

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 5 1 Efficacy_cant_tell
General health 5 0
neuroprotection 3 1 Efficacy_none
Support nutritional health 1 0
ALS (Amyotrophic Lateral Sclerosis) 1 0
Increase Energy 1 0

See all 11 patients currently taking Green Tea Caps/Tabs

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 2

Reported Dosages

  daily 2 mg daily 3 mg daily 150 mg daily 315 mg daily 400 mg daily 500 mg daily 600 mg daily 1,600 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Green Tea Caps/Tabs (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 3   Did not seem to work: 50%
Other 2   Other: 33%
Expense 1   Expense: 17%

See all 6 patients who’ve stopped taking Green Tea Caps/Tabs

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Green Tea Caps/Tabs

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Green Tea Caps/Tabs

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Green Tea Caps/Tabs

Always
 1 50%
Usually
 1 50%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Green Tea Caps/Tabs

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 2 100%

Cost

Paid out of pocket

Cost of Green Tea Caps/Tabs

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

Report created on February 11, 2012.